MPP dihydrochloride 是一种强效的选择性ER(雌激素受体)调节剂。MPP dihydrochloride 可诱导子宫内膜癌和 oLE 细胞凋亡。MPP dihydrochloride 可逆转 β - 雌激素的积极作用。在体内，MPP dihydrochloride 对小鼠子宫ERalpha具有激动剂和拮抗剂的混合作用。
| 生物活性 | MPP dihydrochloride is a potent and selectiveER (estrogen receptor)modulator. MPP dihydrochloride induces significantapoptosisin the endometrialcancerand oLE cell lines. MPP dihydrochloride reverses thepositiveeffects of beta-estradiol. MPP dihydrochloride has mixed agonist/antagonist action on murine uterineERalphain vivo[1][2][3]. |
| IC50& Target | |
体外研究
(In Vitro) | MPP (1, 5, 10, 25, 50 and 100 μM; 24 h) decreases cell viability with an IC50value of 20.01 μM in RL95-2 cells[1].
MPP dihydrochloride shows antiproliferative activity at a concentration of 10 μM in RL95-2 cells[1].
MPP dihydrochloride (20 μM; 24 h) reduces the phosphorylation of ERα, while it does not alter the phosphorylation of Akt. MPP dihydrochloride reduces the ratio of p-ERα/ERα[1].
Cell Viability Assay[1] | Cell Line: | RL95-2 endometrium cancer cells | | Concentration: | 1, 5, 10, 25, 50 and 100 μM | | Incubation Time: | 24 hours | | Result: | The treatment with 25 μM, 50 μM and 100 μM for 24 h decreased cell viability significantly. However, cell viability was not significantly changed by MPP dihydrochloride at concentration below 25 μM. |
Cell Proliferation Assay[1] | Cell Line: | RL95-2 cell | | Concentration: | 10, 15, 20 and 25 μM | | Incubation Time: | 72 hours | | Result: | Showed antiproliferative activity at a concentration of 10 μM. |
Western Blot Analysis[1] | Cell Line: | RL95-2 cell line | | Concentration: | 20 μM | | Incubation Time: | 24 hours | | Result: | Reduced the phosphorylation of ERα, while it did not alter the phosphorylation of Akt. Reduced the ratio of p-ERα/ERα compared to the control group. |
|
体内研究
(In Vivo) | MPP (Low dose 20 μg/kg body weight or high dose 200 μg/kg body weight) leads to a dose-dependent attenuation of percent prepulse inhibition (PPI)[2].
| Animal Model: | Male C57BL/6N mice at the age of 9-10 weeks[2] | | Dosage: | Low dose (20 μg/kg body weight) or high dose (200 μg/kg body weight) | | Administration: | Administered subcutaneously (s.c.) injected; injection volume of 5 mL/kg; 60 min before PPI testing | | Result: | Led to a dose-dependent attenuation of percent PPI. Pretreatment with 200 μg/kg reduced the mean percent PPI scores by ~30%. |
|
| 分子量 | |
| 性状 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| 溶解性数据 | In Vitro: DMSO : 30 mg/mL(55.30 mM;Need ultrasonic and warming) 配制储备液 | 1 mM | 1.8433 mL | 9.2166 mL | 18.4332 mL | | 5 mM | 0.3687 mL | 1.8433 mL | 3.6866 mL | | 10 mM | 0.1843 mL | 0.9217 mL | 1.8433 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。 |
m.cnreagent.com